Definitive Healthcare Corp. (DH) · Nov 5, 2026 · Earnings

Definitive Healthcare earnings beat, but revenue and margins slide

Beat — Adj. EPS $0.06 vs ~$0.04 consensus

Definitive Healthcare’s Q3 earnings beat profit expectations, but revenue fell 9%, margins weakened and the company offered no guidance.

Definitive Healthcare is a healthcare data and analytics company trying to stabilize a shrinking revenue base while integrating new leadership and operating under the shadow of Advent’s proposed take-private transaction. The company had already warned that 2026 revenue would decline amid disruption in the healthcare claims-data market, and Clay Ritchey became CEO in September as part of a leadership reset.

The quarter beat the published profit bar, but only narrowly on revenue. Revenue of $54.7 million was just above the published consensus of roughly $54.57 million, while adjusted EPS of $0.06 exceeded the roughly $0.04 expectation. The company had guided Q3 revenue to $54.0–$55.0 million and adjusted net income to $5.5–$6.5 million, so execution landed inside its own range rather than resetting the business outlook.

Q3 2026Q3 2025Consensus
Revenue (Financial Highlights)$54.7M$60.0M$54.57M
Adjusted net income per share (Reconciliation)$0.06$0.07$0.04
Adjusted EBITDA (Financial Highlights)$15.7M$18.9M
Adjusted EBITDA margin (Financial Highlights)29%32%
Cash flow from operations (Financial Highlights)$11.4M$15.7M

The core operating trend remains weak. Revenue fell 9% year over year, adjusted EBITDA declined about 17%, and the margin contracted three percentage points to 29%. That means the profit beat came from outperforming a low bar and tighter cost control, not from renewed top-line momentum.

Cash generation also deteriorated despite the cleaner GAAP loss. Operating cash flow fell to $11.4 million from $15.7 million, while adjusted net income declined to $8.8 million from $9.7 million. The smaller net loss is therefore not evidence of a broad operating recovery; the business is still producing cash, but at a lower rate.

The missing outlook is understandable but leaves the turnaround harder to judge. Definitive Healthcare withheld guidance and its conference call because Advent’s September 2 non-binding $1.02-per-share buyout indication is under review, a development already known before this earnings release. That makes the omission mostly confirmation rather than new information, but it removes the clearest near-term benchmark for whether the new CEO can reverse the revenue decline. 〔0〕

Bottom line: Definitive Healthcare beat a modest quarterly profit expectation, but the underlying business is still shrinking and becoming less profitable. The result modestly improves near-term execution credibility without changing the larger turnaround story.ank

What to watch next

Advent special committee decision on the buyout proposal

Original filing on SEC EDGAR

Definitive Healthcare earnings beat, but revenue and margins slide | DH Stock News
AllSight

Breaking down Wall Street's
information edge.

A buy-side analyst on every ticker — it reads every public company's filing the instant it drops and decodes it into plain English.

—
8-K events this week
—
filings analyzed in total
live · updated 30s ago
Live events · whole market · · --:--:-- ET
AllSight read
Straight from the 8-K
Verbatim from the filing AllSight decoded — highlighted above. Open on SEC EDGAR ↗
Limited-time offerFree 14-day Pro trial
AllSight

Sign in to AllSight

  • Follow any company — we email you the moment it files, free!
  • Your watchlist saved to your account, on every device — free!

by Signing in NOW, claim your FREE 14-day Pro trial!

No password. We email you a 6-digit code. By continuing you agree to our Terms & Privacy.
AllSight · Live plain-English 8-K decodes across the whole US market · Not investment advice.